4//SEC Filing
Sperzel John J III 4
Accession 0000899243-22-008054
CIK 0001492674other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:00 PM ET
Size
8.7 KB
Accession
0000899243-22-008054
Insider Transaction Report
Form 4
Sperzel John J III
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-02-24+333,333→ 333,333 total - Exercise/Conversion
Restricted Stock Units
2022-02-24−333,333→ 666,667 total→ Common Stock (333,333 underlying) - Tax Payment
Common Stock
2022-02-24$0.45/sh−141,560$63,532→ 191,773 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]141,560 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On February 24, 2021 the reporting person was granted 1,000,000 RSU's that vest in three equal installments commencing on February 24, 2022.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001602618
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:00 PM ET
- Size
- 8.7 KB